Grants and Contributions:
Title:
ARP - Development of a synthetic pathway for a fatty acid-derived compound
Agreement Number:
902556
Agreement Value:
$48,462.00
Agreement Date:
Apr 2, 2018 - Mar 29, 2019
Description:
Development of a scalable chemical synthesis pathway allowing to produce fatty acid-derived compounds with health benefits .
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Quebec, Quebec, CA G1V 0B9
Reference Number:
172-2018-2019-Q1-902556
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
806535035
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 92 days.
Amendment Date
Dec 11, 2018
Recipient's Legal Name:
Maresins Pharma, inc.
Federal Riding Name:
Louis-Hébert
Federal Riding Number:
24044
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: